About NuVasive
NuVasive is a company based in San Diego (United States) founded in 1997 was acquired by Globus Medical in February 2023. NuVasive has raised $54.1 million across 5 funding rounds from investors including Kleiner Perkins, Globus Medical and Johnson & Johnson Innovation – JJDC. NuVasive has completed 7 acquisitions, including Biotronic, Ellipse Technologies and Globus Medical. NuVasive offers products and services including XLIF, C360, P360, and Pulse. NuVasive operates in a competitive market with competitors including Stryker, Ensoma, In'Tech Medical, CARLSMED and Orthofix, among others.
- Headquarter San Diego, United States
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$54.1 M (USD)
in 5 rounds
-
Latest Funding Round
$400 M (USD), Post-IPO
May 26, 2020
-
Investors
Kleiner Perkins
& 6 more
-
Employee Count
Not available
-
Investments & Acquisitions
Biotronic
& 6 more
-
Acquired by
Globus Medical
(Feb 09, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NuVasive
NuVasive offers a comprehensive portfolio of products and services, including XLIF, C360, P360, and Pulse.
Minimally invasive lateral lumbar fusion technique
Integrated solutions for anterior and posterior procedures
Techniques for open and less-invasive posterior surgeries
Platform to enhance surgical workflows and outcomes
People of NuVasive
Unlock access to complete
Unlock access to complete
Software Development Team
159 people
Leadership Team
66 people
Sales and Marketing
61 people
Product Management Team
41 people
Spine Team
21 people
Senior Team
15 people
Legal and Compliance
9 people
Operations Team
7 people
Unlock access to complete
Funding Insights of NuVasive
NuVasive has successfully raised a total of $54.1M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $400 million completed in May 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NuVasive
NuVasive has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Kleiner Perkins, Globus Medical and Johnson & Johnson Innovation – JJDC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backed by Johnson & Johnson
|
Locked | Locked | Locked | |
|
VC firm focusing on life science sector
|
Locked | Locked | Locked | |
|
Venture capital firm investing in early-stage tech startups
|
Locked | Locked | Locked |
Investor details for NuVasive
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NuVasive
NuVasive has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Biotronic, Ellipse Technologies and Globus Medical.
Investment portfolio details for NuVasive
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Globus Medical is engaged in developing innovative medical devices for spine and orthopedic solutions.
|
Locked | Locked | 2013 | Locked | |
|
Develops fusion devices using patented porous PEEK technology
|
Locked | Locked | 2013 | Locked | |
|
Low-radiation fluoroscopic images are enhanced for better resolution and contrast.
|
Locked | Locked | 2012 | Locked |
Complete acquisition details for NuVasive
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - NuVasive
Detailed financials for NuVasive
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nuvasive Comparisons
Peer comparison for NuVasive
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NuVasive
NuVasive operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Stryker, Ensoma, In'Tech Medical, CARLSMED and Orthofix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
3D-printed orthopedic products are manufactured for medical applications.
|
|
| Locked | Locked | Locked |
Provider of in vivo stem cell modification technologies and vector-based drug delivery tool
|
|
| Locked | Locked | Locked |
Surgical instruments for orthopaedics are developed and manufactured.
|
|
| Locked | Locked | Locked |
Developer of devices for spine surgery
|
|
| Locked | Locked | Locked |
Reconstructive and regenerative solutions for bone conditions are developed.
|
Detailed competitors of NuVasive
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nuvasive
Complete news archive for NuVasive
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NuVasive
NuVasive was founded in 1997 and raised its 1st funding round 4 years after it was founded.
NuVasive is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
NuVasive is a funded company, having raised a total of $54.1M across 5 funding rounds to date.
NuVasive was founded in 1997 in San Diego, United States, as a developer of medical devices focused on spinal surgery. Operations include the marketing of seven products, such as the stem cell-based Osteocel, and the NVM5 system for intraoperative neuromonitoring. The company went public in 2012 and acquired Ellipse Technologies, an orthopedic device maker, in January 2016. Activities center on orthopedic innovations in the healthcare sector.
NuVasive offers XLIF, C360, P360, and Pulse.
NuVasive has made 7 acquisitions, including Biotronic, Ellipse Technologies, and Globus Medical.
NuVasive has 7 investors. Key investors include Kleiner Perkins, Globus Medical, Johnson & Johnson Innovation – JJDC, William Blair, and Pappas Capital.